Apollo Endosurgery

Apollo Endosurgery, Inc. is a medical technology company focused on revolutionizing patient care through the development of innovative endoscopic surgical products. The company specializes in minimally invasive procedures, particularly in the field of bariatrics, which deals with weight loss surgeries, and other gastrointestinal interventions. Apollo Endosurgery serves a diverse range of clients, including hospitals, clinics, and specialized medical practitioners across more than 80 countries.

Operating in the global healthcare market, Apollo Endosurgery targets the growing demand for less invasive surgical options. Their product portfolio includes devices like the Orbera Intragastric Balloon, which helps patients lose weight without the need for traditional surgery, and the OverStitch Endoscopic Suturing System, which allows for complex suturing procedures to be performed endoscopically (using a flexible tube inserted into the body).

The company's business model revolves around the development, manufacturing, and distribution of these medical devices. Revenue is generated primarily through the sale of these products to healthcare providers and medical institutions. Additionally, Apollo Endosurgery offers training and support services to ensure that medical professionals can effectively use their products, further enhancing their revenue streams.

Apollo Endosurgery is listed on the NASDAQ under the ticker symbol APEN, indicating its status as a publicly traded company. This listing provides the company with access to capital markets, enabling it to fund research and development, expand its product offerings, and enter new markets.

In summary, Apollo Endosurgery is a key player in the medical technology sector, focusing on innovative, minimally invasive surgical solutions that improve patient outcomes and reduce recovery times.

Keywords: endoscopic surgery, bariatrics, weight loss, minimally invasive, medical devices, gastrointestinal, Orbera, OverStitch, healthcare, NASDAQ APEN.